hypertension
Individuals at enhanced polygenic risk of high systolic blood pressure had increased treatment resistance risk and less pronounced response to chlorthalidone in a new study.
PolygenRx Wants to Use Genetics to Guide Chronic Disease Treatments, Starting With Hypertension
Premium
The Australia-based startup wants to partner with drugmakers on biomarker-defined clinical trials and create clinical decision-support software.
Additional Blood Pressure Contributors Uncovered in Large GWAS Meta-Analysis
The loci uncovered in the meta-analysis provided clues to blood pressure biology and enabled the development of new polygenic risk scores.
Scores focused on the biochemical pathways associated with disease and pairing these scores with other risk assessments could improve predictive value, the data showed.
Blood Pressure GWAS Highlights Sex-Specific Risk Variants, Links to Cardiovascular Disease
Researchers tracked down 29 new blood pressure-associated genetic loci, along with 1,346 loci linked to the trait in the past.